Home › Obesità › Georgia › South Fulton
Studi clinici su Obesità a South Fulton, GA
12 studi su Obesità cercano partecipanti presso sedi a South Fulton e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
In reclutamentoFase 3
- Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group, Union City · a 8 mi di distanza
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
In reclutamentoFase 3
- AURORA-2 Clinical Site, Union City · a 8 mi di distanza
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
In reclutamentoFase 3
- Privia Medical Group Georgia LLC, Peachtree City · a 14 mi di distanza
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
In reclutamentoFase 3
- AURORA-1 Clinical Site, Union City · a 8 mi di distanza
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
In reclutamentoFase 3
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City · a 8 mi di distanza
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
In reclutamentoFase 2
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City · a 8 mi di distanza
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
In reclutamentoFase 3
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City · a 8 mi di distanza
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
In reclutamentoFase 3Volontari sani benvenuti
- ACCOMPLISH-2 Research Site, Union City · a 8 mi di distanza
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
In reclutamentoFase 2
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City · a 8 mi di distanza
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
In reclutamentoFase 4
- Southeast Research Specialists, Douglasville · a 12 mi di distanza
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
In reclutamentoFase 3
- Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group, Union City · a 8 mi di distanza
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
In reclutamentoFase 3
- ACCOMPLISH-1 Research Site, Union City · a 8 mi di distanza
Studi su Obesità in altre città
- Houston, TX43 studi
- Chicago, IL41 studi
- New York City, NY40 studi
- San Antonio, TX40 studi
- Washington, DC33 studi
- Orlando, FL32 studi
- Dallas, TX30 studi
- Boston, MA28 studi
- Las Vegas, NV27 studi
- Miami, FL27 studi
- Baltimore, MD26 studi
- Jacksonville, FL25 studi
Altri studi a South Fulton
- Sovrappeso11 studi
- Cancro del polmone non a piccole cellule8 studi
- Diabete di tipo 27 studi
- Cancro ai polmoni7 studi
- Cancro al seno5 studi
- Leucemia linfatica cronica4 studi
- Cancro colorettale4 studi
- Insufficienza cardiaca4 studi
- Cancro (tutti i tipi)3 studi
- Cancro alla prostata3 studi
- Mieloma multiplo3 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.